Covation Bio

Biotechnology Research • Newark, Delaware, United States • 51-100 Employees

Company overview

Headquarters	800 Prides Crossing, Suite 201, Newark, Delaware 19713, US
Website	covationbio.com
NAICS	541714
Employees	51-100
Socials

Key Contacts at Covation Bio

Alexa Girardi Raab

Director Of Global Communications

Dan Slanac

Global Technology Director

Dean Trivits

Chief Executive Officer

Kurt Rupprecht

Global Business Director

Lindsay Cox

Global Product And Planning Director

Covation Bio Email Formats

Covation Bio uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@covationbio.com), used 57.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@covationbio.com	57.1%
{first initial}.{last name}	j.doe@covationbio.com	40.5%
{last name}	doe@covationbio.com	2.4%

About Covation Bio

Founded in 2022, in Newark, Delaware, Covation Biomaterials is a leading global innovator offering a product portfolio of high-performance, sustainable solutions. The company builds on its rich DuPont legacy of groundbreaking scientific innovation and continues to deliver novel solutions at scale across multiple industries including apparel, carpeting, cosmetics, food and packaging. Through product lines such as Sorona, Susterra, and Zemea, the mission of Covation Biomaterials is to deliver the sustainable building blocks that will enable customers to provide bio-based products accessible to everyone.

Covation Bio revenue & valuation

Annual revenue	$5,389,965
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,300,000
Total funding	No funding